secwatch.observer — SEC 8-K summary
======================================

Issuer:     ACRO BIOMEDICAL CO., LTD. (ACBM)
CIK:        0001622996
Form:       8-K
Filed at:   2026-09-02T20:05:24+00:00
Accession:  0001640334-26-001447
Event type: leadership
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Acro Biomedical appoints new chairman and CEO; Su resigns
---------------------------------------------------------

- Yu-Ting Su resigned as director, chairman, and CEO on Sept 2, 2026, effective immediately.
- Board appointed Shao-Hsiang Shih as director and chairman, effective Sept 2, 2026.
- Jing-Zhou Chen appointed CEO and CFO, effective Sept 2, 2026.
- Su's resignation was not due to any disagreement with the company.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1622996/000164033426001447/0001640334-26-001447-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1622996/000164033426001447/acbm_8k.htm
  HTML page:      https://secwatch.observer/filing/0001640334-26-001447

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer